The hemostatic balance in HIV-infected patients with and without antiretroviral therapy: partial restoration with antiretroviral therapy

AIDS Patient Care and STDs
Eefje JongEric C M van Gorp

Abstract

The incidence of arterial and venous thrombosis in HIV-infected patients is increased compared to healthy controls. In this cross-sectional analysis we measured markers of endothelial cell activation, thrombin generation, fibrinolysis and anticoagulation combined with endogenous thrombin potential (ETP) and activated protein C sensitivity ratio (APCsr) as more global markers. We included 160 consecutive HIV-infected patients with a median age of 46 years (range, 27-77), of whom 92% were male, 74% Caucasian, 11% African American, 9% Hispanic, and 6% Asian. Homosexual contact was the main transmission mode. Seventy percent of patients were using combined antiretroviral therapy (cART). In 83% of patients laboratory markers outside the normal range for a non-HIV-infected population were observed. Significant lower levels of von Willebrand factor (vWF; p = 0.03), factor VIII (p < 0.0001), D-dimer (p = 0.01), and ETP (p = 0.01) were observed in HIV-infected patients on cART compared to patients not on cART. Significant lower levels of protein C (p = 0.05) and free protein S (p < 0.0001), and increased APCsr (p < 0.0001) were found in the HIV-infected patients not on cART. A single association was observed between raised levels of fib...Continue Reading

References

Oct 28, 1995·Lancet·D C ReesJ B Clegg
Mar 17, 2001·Haemostasis·S P Frostick
Dec 14, 2002·Lancet·Scott D HolmbergUNKNOWN HIV Outpatient Study (HOPS) investigators
Sep 19, 2003·Pathophysiology of Haemostasis and Thrombosis·H C HemkerS Béguin
Nov 6, 2003·AIDS·Murielle Mary-KrauseUNKNOWN Clinical Epidemiology Group from the French Hospital Database
Nov 25, 2003·The New England Journal of Medicine·Nina Friis-MøllerUNKNOWN Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
Feb 26, 2004·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Abraham Majluf-CruzLeopoldo Nieto-Cisneros
Mar 31, 2004·The American Journal of Medicine·Peter Libby, Paul M Ridker
Mar 19, 2005·Circulation Research·Radjesh J BisoendialErik S G Stroes
Jul 19, 2006·British Journal of Haematology·Anne-Cornélie J M de PontJoost C M Meijers
Sep 12, 2006·Journal of Thrombosis and Haemostasis : JTH·W M LijferingJ van der Meer
Dec 21, 2006·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Eelco W MeestersHugo ten Cate
Apr 7, 2007·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Evy MicieliWalter Ageno
Apr 27, 2007·The New England Journal of Medicine·UNKNOWN DAD Study GroupJens D Lundgren
Jun 22, 2007·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Willem M LijferingJan van der Meer
May 3, 2008·Clinical Chemistry·Willem M LijferingJan van der Meer
Jul 9, 2008·Scandinavian Journal of Infectious Diseases·Maria R AtienzaEnrique Calderón
Aug 12, 2008·Thrombosis and Haemostasis·Arina J ten Cate-HoekHugo ten Cate
Sep 12, 2008·AIDS Patient Care and STDs·Nancy F Crum-CianfloneMary Bavaro
Oct 24, 2008·PLoS Medicine·Lewis H KullerUNKNOWN INSIGHT SMART Study Group
Nov 18, 2008·European Journal of Internal Medicine·Massimo Franchini, Pier Mannuccio Mannucci
Dec 17, 2008·AIDS Patient Care and STDs·Oluwatoyin AdeyemiNeena Thomas-Gossain

❮ Previous
Next ❯

Citations

Aug 17, 2010·Journal of Thrombosis and Thrombolysis·Richard C Becker
Dec 17, 2010·International Journal of Hematology·Alireza AbdollahiAhmad Ahmadzadeh
Oct 28, 2010·Current Opinion in HIV and AIDS·Daniel E Nixon, Alan L Landay
Jun 15, 2011·PLoS Neglected Tropical Diseases·Peter Mark JourdanEyrun Floerecke Kjetland
Apr 9, 2011·Biomarkers in Medicine·Gregor F LichtfussSharon R Lewin
Mar 23, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Priscilla Y HsueEthan J Weiss
Oct 22, 2013·Immunity·Steven G DeeksDaniel C Douek
Mar 31, 2015·Frontiers in Microbiology·Lennert W J van den DriesMarchina E van der Ende
Oct 27, 2010·HIV Clinical Trials·Alan R Lifson INSIGHT Study Group
May 15, 2020·PLoS Medicine·Casper RokxUNKNOWN ATHENA observational HIV cohort
Nov 19, 2019·Open Forum Infectious Diseases·Elizabeth S Mayne, Susan Louw
Jan 19, 2017·AIDS·Jessica L MontoyaUNKNOWN HIV Neurobehavioral Research Program (HNRP) Group
Nov 7, 2019·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Elizabeth S MayneSusan Louw
Feb 13, 2020·PloS One·Marilza Campos de MagalhãesSoniza Vieira Alves-Leon
Jan 26, 2021·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Wouter A van der HeijdenQuirijn de Mast

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay
ELISA

Software Mentioned

Statistical Package for Social Sciences
SPSS
Thrombinoscope software

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.